Novo Nordisk A/S announced the conclusion of its share repurchase program on August 5, 2024, having repurchased a total of 11,067,126 B shares valued at DKK 9.73 billion since February 6, 2024. The program aimed to buy back up to DKK 20 billion worth of shares over 12 months, starting May 6, 2024.